Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory Trial

Parkinson's disease (PD) is a disorder characterized by loss of dopamine (DA) in the nigro-striatal dopamine (NSD) system with the primary symptoms of bradykinaesia, rigidity, tremor, and altered gate. Secondary symptoms including depression, insomnia, involuntary movement, and psychiatric side...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Gregory L., Boda, Jamilee, Freelance, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156259/
https://www.ncbi.nlm.nih.gov/pubmed/30778331
http://dx.doi.org/10.3389/fneur.2018.00741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156259/
https://www.ncbi.nlm.nih.gov/pubmed/30778331
http://dx.doi.org/10.3389/fneur.2018.00741

Ejemplares similares